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1. Introduction 
The burden of skin disease is high in developing countries particularly the sub-Saharan 
Africa. The HIV/AIDS epidemic does not make it any better. More than 90% of HIV positive 
patients may develop mucocutaneous problems at one stage of the disease or the other with 
significant morbidity and mortality. 
The aim is to highlight common cutaneous manifestations of HIV/AIDS in sub-Sahara 
Africa. A good knowledge of these cutaneous lesions may aid in early diagnosis and 
appropriate treatment of HIV infection. 
2. Cutaneous manifestations of HIV/AIDS 
Cutaneous manifestations are common in patients with HIV infection in the sub-Saharan 
Africa and can be broadly classified into infection/infestation, malignancy, and cutaneous 
hypersensitivity. It may be the sentinel event that brings the patient to the physician. 
Majority of HIV-infected patients will have dermatologic problem at some time during their 
illness. This may provide a more accurate measure of the disease progression than other 
organs because the skin is much accessible (Johnson, 1999). 
Skin disorders are mostly attributable to the alterations in immune function. Some of the 
skin diseases are unique to HIV infection, while some are really not new diseases (Aftergut 
and Cockerell , 1999; Olumide, 2002).  The later diseases may be more widespread, have an 
unusual character or a more prolonged course and may be resistant to therapy.  The affected 
individuals have a significantly increased incidence of skin complaints which rises as HIV 
infection progresses (Wiwanitkit, 2004).  In the asymptomatic stage of HIV infection, 
cutaneous manifestations are non-specific.  Common cutaneous disorders present with 
atypical features for instance, shingles (VZV) may be severe, recurrent, haemorrhagic or 
affect more than one dermatome; warts may be multiple and large. Seborrhoeic dermatitis, 
pityrosorum folliculitis, eosinophilic pustulosis and bacilliary angiomatosis are all well 
recognized.  In the later symptomatic stages, in addition to those infections mentioned 
above, the following should also be remembered: mycobacterium tuberculosis and atypical 
mycobacteria, candida species; Trichophyton rubrum, Malassezia furfur, chronic herpes 
simplex, florid molluscum contagiosum. Neoplastic processes, especially Kaposi’s sarcoma 
make their appearance at this time. 
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2.1 Mycobacteria 
These organisms are important causes of systemic infection in HIV disease, but cutaneous 
lesions have also been recognized, both direct infection and papulonecrotic tuberculide. 
Cutaneous lesions of mycobacterium avium complex (MAC) include nodules (Fig 1), 
ulcerations, pustules abscesses, folliculitis and lymph adenitis.  Cutaneous lesions of 
mycobacterium tuberculosis (TB) include scrofuloderma, papules, vesicles, necrotic 
ulcerations, subcutaneous nodules and pustules.  Bacillus calmette – Guerin (BCG) vaccine 
may cause local and systemic infection in HIV patients especially after signs of defective 
immunity have appeared, it is regarded as contra-indicated except for children as yet 
asymptomatic in areas of high risk for tuberculosis. 
 
 
Fig. 1. Cutaneous nodule of Tuberculosis in HIV 
The treatment of mycobacterium tuberculosis is the conventional DOTS using rifampicin, 
isonazid, ethambutol and pyrazinamide.  It is recommended that for MAC treatment 
regimen should include at least 2 agents, with ethambutol being one of the agents. 
2.2 Syphilis 
Syphilis is a sexually transmitted disease due to infection with Treponema pallidum.  Both 
syphilis and HIV infection are sexually transmitted diseases and so could occur 
concurrently (Olumide; 2002). 
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Unusual courses of syphilis have been reported in HIV infections.  Not only may the 
serological response to T. pallidum be impaired but also syphilis may progress much more 
rapidly to advanced stages than in individuals without HIV.  Moreover syphilis in patients 
with HIV infection may not respond to conventional treatment.  Skin signs of syphilis in 
HIV infected patients are usually similar to that of HIV – negative patients but are often 
extensive and atypical. 
A severe form of secondary syphilis or lues, ‘syphilis maligna’ can occur in HIV patients 
with papular, papulovesicular, pustular and necrotizing lesions which may form thick 
crusts and painful ulcers accompanying severe systemic symptoms .  Tertiary gummata and 
neurosyphilis also appear more common. 
Recommended treatment is benzathine penicilin 2.4 million units intramuscularly in a single 
dose given as 1.2 million units in each buttock.  The treatment is repeated in a week.  If there 
is central nervous system involvement 2.4 million units of aqueous penicillin is given 
intravenously every 4 hours for 10 – 14 days. This is because intramuscular benzathine 
penicillin does not give therapeutic levels in the CSF. 
2.3 Staphylococcus aureus 
Skin infections with Staph aureus are quite common in HIV infected patients and the 
frequency increases with progression of immune-deficiency.  Not only is Staph aureus the 
most common bacterial pathogen in HIV infected patients but also a large percentage of 
patients become chronic carriers.  Apart from the types of skin lesions commonly associated 
with Staph aureus in patients without HIV such as folliculitis, impetigo, ecthyma, abscesses 
and cellulitis, more unusual manifestations such as atypical plaque – like folliculitis, 
pyomyositis or botryomycosis are frequently encountered during HIV diseases. 
Botryomycosis is characterized by chronic, Suppurating, granulomatous lesions which may 
present as inflammatory nodules, discharging ulcers, sinuses and fistulae.  The lesions 
usually solitary can occur in the skin, liver, bones, etc, and on gross examination of the pus, 
pinhead – sized whitish yellow granules are evident.  The granules simply contain a central 
mass of bacteria surrounded by a capsule and can be demonstrated on biopsy or smear of 
the purulent focus.  The capsule is usually periodic – Acid – Schiff (PAS) positive. 
Botryomycosis is caused by bacteria with Staph aureus usually the major causal agent and 
Pseudomonas aeruginosa ranking second in frequency. The therapy of choice is surgical 
excision in conjunction with antibiotics. 
2.4 Bacillary angiomatosis 
These angioma-like lesions may affect skin, mucosal surfaces and internal organs, 
Cutaneous lesions typically begin as tiny pinpoint papules, resembling Campbel de Morgan 
sports, often in large numbers and very widespread. They enlarge rapidly both outwards 
and inwards, looking like pyogenic granulomas and subcutaneous nodules. They may 
resemble some forms of AIDS-related Kaposi’s sarcoma (and indeed the two may coexist 
but can generally be distinguished by their faster growth, bright red color and rounder 
shape, with no elongation along skin crease). If injured, lesions bleed profusely. Visceral 
lesions may occur and deaths from laryngeal obstruction and disseminated intravascular 
obstruction are recorded. Bacillary angiomatosis has been seen mainly in HIV disease, but 
also in other immunodeficient patients and rarely in the otherwise healthy. It is caused by 
Bartonella henselae or occassional B. quintana, argyrophilic bacilli. Confirmation of diagnosis 
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is by recognition of histological features or by PCR amplification of the organism’s nucleic 
acid obtained from biopsy tissue.  
Treatment – the recommended treatment for bacillary angiomatosis is erythromycin 500mg 
qds.  If the patient has severe disease or can not tolerate orally, intravenous erythromycin 
can be given. Alternative to erythromycin include doxycline 100mg bid; minocycline 100mg 
bid or tetracycline 50mg qid, treatment should continue for 8-12 weeks and in case of 
systematic disease 3-4 months. 
2.5 Demodicidosis 
Folliculitis due to Demodex folliculorum may cause an itchy papular eruption in HIV patients. 
Affected areas include head and neck, and trunk and arms Microscopy of smears or 
scrapings, or histology confirms the presence of numerous mites. There is a rapid response 
to topical treatment with insecticides such as y-benzene hexachloride. 
2.6 Viral infection 
Viruses other than HIV-1 are common pathogens in HIV-1 disease and are probably 
important infectious co-factors for disease progression (Sterling and Kurtz, 1998). These 
opportunistic infections range from relatively benign disorder such as cosmetically 
disfiguring molluscum contagiosum to severe infections of the skin and mucus membranes 
such as ulcerating herpes simplex and oral hairy leukoplakia, which is attributed to Epstein 
Barr virus infection. 
2.7 Herpes simplex 
Chronic painful, non-healing ulcers found in herpes simplex virus (HDV) infections are 
commonly located at the junction between skin and mucous membranes, mainly in the 
perioral and perianal areas. Chronic ulcerating herpes simplex must first be differentiated 
from conventional recurrent HSV infection. Whereas the latter can occur at any stage of 
HIV-1 disease and is clinically and morphologically indistinguishable from the blistering 
eruptions commonly seen in patients without HIV-1 infection, the former heralds profound 
immunodeficiency. Chronic ulcerating herpes simplex is one of the AIDS-defining 
opportunistic infection according to Centers for Disease Control and Prevention. Systemic 
antiviral treatment is essential since these lesions show no tendency to resolve 
spontaneously. The differential diagnosis, which depends on the location of the lesions, 
includes pyoderma gangrenosum, bacterial and fungal infection, and cutaneous 
manifestation of lymphomas. 
The recommended treatment for primary or recurrent HSV injection is oral acyclovir. In 
severe infections, intravenous acyclovir can be used. Other alternatives include famciclovir 
and fascarnet. 
2.8 Varicella-zoster 
Clinical manifestation of infection with the varicella-zoster virus (VZV), another member 
of the herpes virus family, depends largely on the age of the patient. Primary VZV 
infection in HIV-1 infected children is often severe, with dissemination and pneumoina, 
encephalitis, or pancreatitis. As with adult patients, epidemiological studies indicate that 
the frequency of reactivation of latent VZV, leading to herpes zoster, is greatly increased, 
with a relative risk in one study of 16.9 for HIV-1 infected person over non-infected 
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persons. 8-13% of patients with AIDS have experienced at least one episode of herpes 
zoster and recurrent herpes zoster is observed more frequently in HIV-1 seropositive 
patients than in sero-negative individuals. However, herpes zoster is not a reliable sign 
of profound immunodeficiency because it can occur at any state of HIV infection. 
Clinical manifestations range from an uneventful vesicular eruption in a dermatomal 
pattern, similar to that in non-HIV-1 infected individuals, to severe haemorrhagic and 
necrotic lesions that may extend over several dermatomes, followed by cutaneous 
dissemination. In contrast to the high frequency of systemic dissemination associated 
with primary VZV infection, dissemination is infrequent in conventional herpes  
zoster. Nevertheless, chronic verrucous or ecthymatous VZV infections may persist for 
months.  
2.9 Molluscum contagiosum 
Poxvirus infection causing Molluscum contagiosum is ordinarily self-limited in 
immunocompetent individuals, occurring mainly in children. However, during HIV-1 
disease molluscum contagiosum is seen in up to 20% of patients, and is usually associated 
with established immunodeficiency.  
Characteristics lesions, which appear commonly on the face and in the genital regions, 
include skin-coloured umbilicated papules with one or more central hyperkeratotic pores. 
Individual lesions can grow to more than 1 cm in size and, if located on the face, may be 
disfiguring. If multiple nodular lesions become confluent they are difficult to treat, 
commonly recurring after conventional local destruction. The differential diagnosis includes 
basal-cell carcinoma, common warts, keratacanthoma, atypical mycobacterial infections, 
and, especially, cutaneous manifestations of systemic infections with Cyptococcus neoformans, 
Histoplasma capsulatum, or Penicillium marneffei. Since differentiation of molluscum 
contagiosum from these important fungal infections is often uncertain clinically, 
histopathological confirmation should always be sought. 
Human Papilloma virus- Common warts may occur in unusual locations, with unusual 
severity, and with high frequency in HIV-1 infected patients but they are seldom serious. 
With respect to genital involvement in women (Fig2), both frequency of human papilloma 
virus (HPV) infection and the progression of HPV-associated cervical lesions correlate with 
the level of immune suppression. Moderate to severe cervical dysplasia and carcinoma-in-
situ are part of category B symptomatic conditions in the revised classification system for 
HIV infection. In men, the rate of anogenital HPV infection is high in HIV-1 sero-positive 
and sero-negative homosexuals. However, as for women, HPV prevalence and symptoms 
tend to increase with disease progression. 
3. Fungal infections 
3.1 Dematophyte Infection 
Tinea infections of varying sites do occur and may be chronic and widespread in HIV 
positive patient (Fig 3). The overall frequency is higher in non-infected control population. 
Nail involvement is common and can cause diffuse whitening. Proximal nail whitening or 
proximal subungual onychomycosis, unusual in immunocompetent individuals is regarded 
by some as characteristic of HIV-associated nail infection. 
Treatment is standard with the use of topical and systemic anti-fungal agents. 
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Fig. 2. Genital warts in HIV 
 
 
 
Fig. 3. Extensive tinea cruris and corporis 
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3.2 Candidiasis 
This is common in all stages of HIV infection affecting the skin, nail, genitals and oral 
mucosa.Cutaneous lesions are often located in the intertriginous areas/ skin folds as highly 
pruritic inflamed areas with satellite lesions and/or follicular pustules. In addition to HIV, 
other risk factors are diabetes mellitus, obesity, malignancy, use of immunosuppressive 
therapy and cytotoxic drugs, use of systemic and topical corticosteroids and antibiotic 
therapy, hot humid environment, occlusion e.g. diapers, casts and dressings, blood 
malignancies and neutropenia and skin disease which disturb the cutaneous  barrier e.g. 
psoriasis  and contact dermatitis. 
Nail lesions affect the proximal nail fold and nail plate. Nail fold lesions (paronychia) 
present as painful, erythematous swellings which may discharge purulent material. Genital 
lesions present as pruritic vulvo-vaginitis with discharge of a creamy white material. There 
may be involvement of the perineum with erythematous and satellite lesions. In severe 
cases, the oral mucosa may show extensive white plagues or widespread erythema, and 
esophageal involvement may give rise to dysphagia and retrosternal pain. 
Standard topical therapy will suffice but in severe cases and nail involvement systemic 
therapy may be needed. Fluconazole (50mg daily) has a higher cure rate than ketoconazole 
(20mg daily) and intermittent administration of fluconazole (150mg) also proved effective. 
3.3 Cutaneous malignancies 
Persons infected with Human Immunodeficiency Virus (HIV) are at higher risk for the 
development of certain types of cancers. The AIDS was first reported in the summer of 1981 
in Los Angeles among young homosexuals who were observed to have had a disseminated 
type of Kaposi’s sarcoma and pneumocystis carini infection. 
3.4 Kaposi’s sarcoma 
Kaposi’s sarcoma (KS), the most common tumor in patients with AIDS, is strongly 
associated with immunosuppression (Schwartz et al., 2008). KS is a vascular neoplasm 
affecting the endothelial cell and that affects the skin, and the mucosa, less commonly 
involves other organs like the gastrointestinal tracts, lungs and lymph nodes. KS can occur 
in HIV-negative patients where it typically has a chronic indolent course. In HIV infected 
patients KS has a more aggressive course and may have systemic involvement. 
Epidemiological data suggest that the cause is a sexually transmitted infectious agent and 
this has recently been supported by the finding of herpes virus nucleic acid in Kaposi’s 
sarcoma lesions (Schwartz et al., 2008) .However, this virus called Kaposi’s sarcoma 
associated herpes virus (or human herpes virus type 8) has also been detected in classical 
KS; Gut lymphomas and other skin lesions of AIDS patients. The role of HHV-8 in the 
pathogenesis of Kaposi’s sarcoma is yet to be clearly defined. 
The mucocutaneous lesions of KS are usually asymptomatic vary from the earliest pink 
macules to the thickened papules and plaques which later develop to nodules. Diffuse 
lesions may manifest mainly as oedema. The lesions initially may  appear benign-looking 
and may be misdiagnosed as pigmented naevi, Spitz naevi, dermatofibroma, bruises, 
pyogenic granulomas, malignant melanoma, ecchymosis, molluscum contagiosum or lichen 
planus. The lesions may appear any where on the skin but the tip of the nose and the hard 
palate are common sites. Lesions in the feet may occasionally become warty. Lesions may 
develop at the site of trauma (Kobner Phenomenon). 
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Unlike the metastatic behavior of other malignant tumors, KS is a multifocal neoplasm in 
which each lesion seems to develop de novo from endothelial cells that line lymphatic  or 
blood vessels into skin or visceral. 
Progression of lesions depends upon the immune status. If the CD4+ cell count rises, either 
with or without treatment lesion may regress at least temporary. 
Treatment: This is not curative. Palliative therapy is indicated for lesions that are 
disfiguring, causing pains or with systemic symptoms. 
Local therapy would include: 
a. Surgery for large lesions. This would include the use of excision and laser. 
b. Cryosurgery 
c. Intralesional chemotherapy using vinblastine 
d. The tumor is sensitive to radiotherapy. 
Systemic therapy would include the following: 
a. Chemotherapy including vinblastine, bleomycin, Doxorubicin 
b. Biology response modifiers which include IFN-a, interleukin-2 and intravenous 
immunoglobulin 
c. Antiretroviral therapy 
d. Photodynamic therapy. 
3.5 Other malignancies 
AIDS-related lymphomas are not uncommon and are usually high grade of the 
immunoblastic or small-cell type. 
3.6 Cutaneous hypersensitivity 
This is a group of eruptions in patients with HIV disease. The pathophysiology of some of 
them is not well defined and therapeutic responses have been disappointing. However, 
some explanations have been advised based on some immunologic findings. Monocytes, 
macrophages, epidermal langerhans cells and dendritic cells of the dermis have CD4 antigen 
and are potential targets for infection by HIV. The decrease in langerhans cells as in AIDS 
may lead to altered cell mediated immunity. 
3.7 Xeroderma  
Dry skin is common in HIV/AIDS especially if chronic diarrhea is a masked feature and 
may be related to malabsorption. There is associated prutitus. In more severe cases with 
changes you have acquired ichthyosis. Icythuosis is a disorder of keratinization 
characterized clinically by dry scaly skin. It should be noted that acquired ichthyosis can 
also be found in lymphomas, lepromatous leprosy and sarcoidosis which are conditions 
with reduced immunity. Treatment is the use of emollients. 
3.8 Pruritic Papular Eruption (PPE) of HIV 
PPE of HIV is a unique manifestation of HIV which has not been seen in seronegative 
patients (Eisman, 2006, Machtinger et al., 2004). Clinically, the lesions are red or skin 
coloured papules that are symmetrically disseminated in the trunk, buttocks and extremities 
(Fig 4). The lesions are extremely pruritic. The lesions heal with post inflammatory 
hypopigmentation with new hyperpigmented lesions. The eruptions wax and wane during 
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the course of the illness. The cause of the lesion is not known but most people think that it is 
a hypersensitivity reaction to antigens or a direct effect of the HIV. 
Treatment with antihistamines, phototherapy and photochemotherapy may be used but of 
limited success.Patient education as to the cause of the illness is important. 
 
 
Fig. 4. Pruritic papular of HIV infection 
3.9 Seborrheic Dermatitis 
Seborrheic dermatitis (SD) is a chronic papulosquamous disorder characterized by  
distinctive morphology (red, sharply marginated lesion covered with  greasy looking scales 
and hypopigmentation which is usually seen in dark skinned people) and a distinctive 
distribution in areas with a rich supply of sebaceous glands namely the scalp, forehead, 
eyebrows, lashline, nasolabial folds, beard and post  auricular skin. Other areas include 
presternal region, inter scapular area, axillae, groin and gluteal crease. 
The prevalence of seborrheic dermatitis is around 1-3% in the general population and 40-
83% in HIV/AIDS patients. 
The aetiology of SD is unclear. It has been suggested that the yeast Pityrosporum ovale is 
important in the aetiology of  SD. Clinically, a wide spectrum of lesions exist but 
characteristic distribution; hypopigmented nummular patches which may coalesce to form 
polycyclic  lesion on the back and presternal area; diffuse erythematous hypopigmented 
macules involving the scalp margins and butterfly areas of the face and trunk; scalp and 
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facial involvement presenting as  dandruff and blepharitis; flexural, petaloid and 
pityrosporum folliculitis. 
In Africa, hypopigmentation is a prominent feature which has been explained as a result of 
dicarboxylic acids produced by malassezia causing competitive inhibition of tyrosinase and 
perhaps a direct cytotoxic effect on hyperactive melanocytes (Altraide et al., 2010). 
Seborrheic dermatitis in HIV/AIDS patients occur in varying severity (Altraide et al; 2010). 
It is usually characterized by thick micaceous scales and usually hyperkeratotic and 
inflammatory and more widespread and generalized. 
Conclusion: Skin disorders are common in sub-Saharan African and may present with early, 
severe, unusual and atypical manifestations in the course of HIV infection. Awareness of the 
varied pattern of these manifestations would help in the early diagnosis and management of 
HIV infection, which would in turn decrease the morbidity and improve the quality of life of 
HIV-infected patients. 
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